Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.83 USD | -1.14% | -4.19% | +69.76% |
Financials (USD)
Sales 2024 * | 197M | Sales 2025 * | 218M | Capitalization | 822M |
---|---|---|---|---|---|
Net income 2024 * | -54M | Net income 2025 * | -52M | EV / Sales 2024 * | 4.11 x |
Net cash position 2024 * | 11.13M | Net cash position 2025 * | 41.33M | EV / Sales 2025 * | 3.57 x |
P/E ratio 2024 * |
-15.2
x | P/E ratio 2025 * |
-15.9
x | Employees | 474 |
Yield 2024 * |
0.61% | Yield 2025 * |
-
| Free-Float | 95.74% |
Latest transcript on Silk Road Medical, Inc
1 day | -1.14% | ||
1 week | -4.19% | ||
Current month | -4.19% | ||
1 month | +8.32% | ||
3 months | +27.01% | ||
6 months | +114.30% | ||
Current year | +69.76% |
Managers | Title | Age | Since |
---|---|---|---|
Charles McKhann
CEO | Chief Executive Officer | 55 | Nov. 01 |
Lucas Buchanan
DFI | Director of Finance/CFO | 46 | 09-07-31 |
William Whealon
CTO | Chief Tech/Sci/R&D Officer | - | 20-09-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Don Zurbay
BRD | Director/Board Member | 56 | 18-03-25 |
Kevin Ballinger
BRD | Director/Board Member | 51 | 20-12-02 |
Jack Lasersohn
CHM | Chairman | 71 | 07-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 415 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 20.83 | -1.14% | 411,960 |
24-06-06 | 21.07 | -2.95% | 479,664 |
24-06-05 | 21.71 | +2.84% | 417,611 |
24-06-04 | 21.11 | -0.71% | 568,582 |
24-06-03 | 21.26 | -2.21% | 667,804 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+69.76% | 822M | |
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
+16.92% | 25.62B | |
-6.87% | 23.32B |
- Stock Market
- Equities
- SILK Stock